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1. The autoantibody (ACPA/RF)-mediated inflammatory state, that precedes RA development 
by many years, may underlie premature immunosenescence in RA (chapter 2, this thesis) 
 
2. The systemic immune profile in seropositive arthralgia patients, who are at risk to develop 
seropositive rheumatoid arthritis (SP RA), is highly similar to the immune profile in SP RA patients 
(chapter 3, this thesis). 
 
3. The decline of NK-cells in SAP and in recently diagnosed SP RA suggests that this alteration 
may contribute to disease development rather than represent the consequence of long-term 
inflammation (chapter 4, this thesis). 
 
4. CD56dim NK-cells may be primarily responsible for the enhanced expression of IFN-γ and 
TNF-α, cytokines implicated in RA pathogenesis; although this feature has previously been attributed 
to CD56bright NK-cells (chapter 4, this thesis). 
 
5. The decrease of Th17 lineage cells, defined as CD4+CD161+ T-cells, in early RA correlated 
inversely with CRP and SJC66, suggesting that these cells may migrate to the joint and contribute to 
local inflammation (chapter 5, this thesis). 
 
6. Th17 lineage cells, defined as CD4+CD161+ T-cells, switch to non-classical Th1 cells at the 
level of the joint which is likely mediated by local IL-12 (chapter 5, this thesis; Nistala et al 2010, Proc 
Natl Acad Sci USA). 
 
7. “Although the synovium is the principal site of pathology in the established phase of disease, 
it may not be the site where the disease is initiated” (Gerlag et al 2012, Ann Rheum Dis) 
 
8. “…failures to prove a hypothesis are rarely even offered for publication, let alone accepted 
(…) Yet knowing what is false is as important to science as knowing what is true. The failure to report 
failures means that researchers waste money and effort exploring blind alleys already investigated by 
other scientists” (The Economist, “How science goes wrong”, Oct 19th 2013). 
 
9. “An expert is a person who has made all the mistakes that can be made in a very narrow 
field” (Niels Bohr, 1885-1962, Danish physicist) 
 
10. “Basic research is like shooting an arrow into the air and, where it lands, painting a target” 
(Homer Burton Adkins, 1892-1949, American organic chemist) 
